Cancer Clinical Trial -BiolineRx -BL-8040-PAC.201

Cancer

Status:

Open

ClinicalTrials.gov:

NCT02826486

A Phase IIa, Multicenter, Open-label Study to Assess the Safety and Efficacy of the Combination of BL-8040 and Pembrolizumab in Patients With Metastatic Pancreatic Cancer, the COMBAT Study

Drug

Vaccine: AGI-134

Phase

PH I/II

Condition

Melanoma (cutaneous)

Keywords

Anti-Gal